IDEAS home Printed from https://ideas.repec.org/a/dbk/health/v4y2025ip598id598.html
   My bibliography  Save this article

Prognostic scale for death in critically ill cancer patients due to neurological complications

Author

Listed:
  • Sosa Remón
  • Bautista-Vanegas
  • Antezana-Muñoz
  • Arteaga Iriarte
  • Pérez-Yero
  • Cuba-Naranjo
  • García-Rodríguez
  • Auza-Santivañez
  • Jeréz Alvarez
  • Gómez Triana

Abstract

Introduction: The scales used to predict death in cancer patients are scarce and have not been adequately validated in populations with neurological complications. Objective: To design a prognostic scale for death in critically ill cancer patients due to neurological complications. Method: An observational, prospective cohort study was conducted from January 2017 to 2024 in the Oncology Intensive Care Unit of the Institute of Oncology and Radiobiology in Havana, Cuba. The study population consisted of 265 patients. Clinical, oncological, laboratory, and life support variables were studied. Binary logistic regression analysis was used to determine the variables with the best prognostic power for the model. The final variable was mortality in the Intensive Care Unit. Results: The final model consisted of the following variables: ECOG III (OR: 3.62; 95% CI: 1.05 - 12.46; p= 0.041), absence of pupillary reflex (OR: 9.35; 95% CI: 2.24 - 38.99; p= 0.002), intracranial hypertension (OR: 17.91; 95% CI: 3.02 - 105.91; p= 0.001), hyperglycemia (OR: 5.85; 95% CI: 2.07 - 16.49; p= 0.001), hypoxemia (OR: 19.09; 95% CI: 2.91 - 61.67; p= 0.000) and artificial mechanical ventilation (OR: 9.59; 95% CI: 2.59 – 35.51; p = 0.001). Conclusions: The prognostic score classified mortality into 3 risk groups: low (0 to 2 points), moderate (3 to 6 points), and high (7 to 13 points). Mortality was higher in patients with higher scores. Internal validation showed excellent calibration and discrimination.

Suggested Citation

Handle: RePEc:dbk:health:v:4:y:2025:i::p:598:id:598
DOI: 10.56294/hl2025598
as

Download full text from publisher

To our knowledge, this item is not available for download. To find whether it is available, there are three options:
1. Check below whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a
for a similarly titled item that would be available.

More about this item

Statistics

Access and download statistics

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dbk:health:v:4:y:2025:i::p:598:id:598. See general information about how to correct material in RePEc.

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

We have no bibliographic references for this item. You can help adding them by using this form .

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Javier Gonzalez-Argote (email available below). General contact details of provider: https://hl.ageditor.ar/ .

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.